Cloudbreak Pharma Postpones 2026 Annual General Meeting to 26 June

Bulletin Express
05/20

Cloudbreak Pharma Inc. (HKEX: 02592, “Cloudbreak-B”) has rescheduled its forthcoming Annual General Meeting, originally set for 29 May 2026, to 26 June 2026.

The Board cited the need for additional preparation time as the sole reason for the postponement. All other information contained in the company’s Annual Report for the year ended 31 December 2025 remains unchanged.

As of 20 May 2026, the Board comprises nine directors: • Executive Directors: Dr. Ni Jinsong (Chairman and CEO), Mr. Dinh Son Van, Dr. Yang Rong • Non-Executive Directors: Dr. Li Jun Zhi, Mr. Cao Xu, Mr. Xia Zhidong • Independent Non-Executive Directors: Ms. Nie Sijiang, Mr. Ma Yiu Ho Peter, Mr. Lee Alex Jao Jang

No further amendments to corporate schedules or disclosures were announced.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10